Quinolones exhibit good antibacterial activity against Salmonella spp. isolates and are 27 often the choice of treatment for life-threatening salmonellosis due to multi-drug resistant 28 strains. To assess the properties of quinolones, we performed an in vitro assay to study the 29 antibacterial activities of quinolones against recombinant DNA gyrase. We expressed the S. 30 Typhimurium DNA gyrase A (GyrA) and B (GyrB) subunits in Escherichia coli. GyrA and 31 GyrB were obtained at high purity (>95%) by nickel-nitrilotriacetic acid agarose resin 32 column chromatography as His-tagged 97-kDa and 89-kDa proteins, respectively. Both 33 subunits were shown to reconstitute an ATP-dependent DNA supercoiling activity. Drug 34 concentrations that suppressed DNA supercoiling by 50% (IC 50 s) or generated DNA cleavage 35 by 25% (CC 25 s) demonstrated that quinolones highly active against S. Typhimurium DNA 36 gyrase share a fluorine atom at C-6. The relationships between the minimum inhibitory 37 concentrations (MICs), IC 50 s and CC 25 s were assessed by estimating a linear regression 38 between two components. MICs measured against S. Typhimurium NBRC 13245 correlated 39 better with IC 50 s (R = 0.9988) than CC 25 s (R = 0.9685). These findings suggest that the DNA 40 supercoiling inhibition assay may be a useful screening test to identify quinolones with 41 promising activity against S. Typhimurium. The quinolone structure-activity relationship 42 demonstrated here shows that C-8, the C-7 ring, the C-6 fluorine, and N-1 cyclopropyl 43 substituents are desirable structural features in targeting S. Typhimurium gyrase. 44 45 46 47 48 51 Non-typhoidal Salmonella is the primary foodborne zoonotic agent of salmonellosis in 52 many countries. The global impact of non-typhoidal Salmonella on human health is high, 53 with an estimated 94 million cases and 155,000 deaths each year, of which 80 million are 54 believed to be foodborne [1]. According to the World Health Organization, in most countries 55 participating in the Global Foodborne Infections Network, Salmonella serovar Enteritidis and 56 Salmonella serovar Typhimurium are the most frequently isolated serotypes of Salmonella 57 [2]. Gastroenteritis caused by Salmonella is generally a self-limited illness. However, 58 antimicrobials may be required to treat invasive cases and susceptible groups such as young 59 children, the elderly and immunocompromised patients [3]. In general, chloramphenicol, 60 ampicillin, and trimethoprim-sulfamethoxazole are used to treat salmonellosis, but resistance 61 to these drugs has increased significantly in recent years [4-6]. In the case of invasive and 62 systemic salmonellosis in humans and animals, quinolones are the preferred drugs for 63 treatment.
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carried out as previously described [14] [15] [16] . Supercoiled, rather than relaxed, pBR322 DNA 151 was used as the substrate for cleavage assays. The reaction mixture (total volume, 30 μl) 152 contained DNA gyrase assay buffer, purified GyrA and GyrB (3 μM each), supercoiled 153 pBR322 DNA (0.3 μg) and 2-fold serially diluted concentrations of ten quinolones. After 154 incubation for 20 min at 35°C, 3 μl of 2% SDS and 3 μl of proteinase K (1 mg ml -1 ) were 155 added to the reaction mixture. After additional incubation for 30 min at 35°C, reactions were 156 stopped to allow a relaxation activity by the addition of 3 μl of 0.5 mM EDTA, 30 μl 157 chloroform-isoamyl alcohol (24:1 mixture, v/v) and 3 μl of 10×DNA loading dye. The activity relationship analysis based on the S. Typhimurium WT QRDR sequence were highly 251 concordant with those based on the E. coli WT QRDR sequence, which has a 100％ identical 252 QRDR sequence with S. Typhimurium (Fig. 7 ). As summarized in Table 3, IC 
